thyroid cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 60 years (covering the main working-age population and capable of completing the questionnaire effectively); 2. Postoperative pathology-confirmed differentiated thyroid carcinoma (papillary or follicular carcinoma), with AJCC 8th edition clinical stage cT1N0-1aM0 (low-risk patients with good prognosis, better highlighting the impact of nursing interventions on quality of life); 3. Having undergone total thyroidectomy or lobectomy + central neck dissection; 4. Karnofsky Performance Status (KPS) score >= 90 (essentially capable of self-care and reliably completing follow-up); 5. Possessing basic literacy and comprehension skills, able to independently or with assistance complete the Chinese version of the questionnaire; 6. Voluntary participation in this study and signing of the informed consent form approved by the hospital ethics committee.
Exclusion criteria
Exclusion criteria: 1. History of other organ malignancies (except non-melanoma skin cancer); 2. Presence of severe uncontrolled comorbidities, such as: unstable angina, recent myocardial infarction, chronic heart failure (NYHA class III-IV), severe chronic obstructive pulmonary disease, advanced hepatic or renal insufficiency, poorly controlled diabetes (HbA1c > 9%), etc.; 3. Postoperative severe complications requiring reoperation or prolonged hospitalization (>14 days), such as: symptomatic hypocalcemia requiring intravenous calcium supplementation, recurrent laryngeal nerve injury causing severe dyspnea, wound infection requiring open drainage, etc.; 4. Severe psychiatric or psychological disorders diagnosed according to DSM-V criteria (e.g., major depressive episode, schizophrenia, bipolar disorder, etc.) or cognitive impairment, judged by the investigator as likely to affect study participation or the reliability of questionnaire responses; 5. Planned relocation or inability to ensure completion of regular follow-up visits within the next 12 months; 6. Concurrent participation in other interventional clinical studies that may affect quality of life.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scores at 5 follow-up time points in the global health/QOL domain; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30: Scores for all functional domains and symptom domains at time points T1-T5. - EORTC QLQ-THY34 Chinese version: Scores at T1-T5 for all symptom domains.; | — |
Countries
China
Contacts
Fujian Province Cancer Hospital